ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันอังคารที่ ๑๙ มิถุนายน พ.ศ. ๒๕๖๑ ๑๓:๑๗ น.

Food and Healthcare Press Releases

KTC in association with Bangkok Hospital give a talk on Minimally Invasive Surgery and offer a package of Ovarian and Uterine Cancer Screening. Heathcare—๑๒ มิ.ย. ๖๑

"KTC" or Krungthai Card Public Company Limited by Ms. Sireerat Corvanich, Vice President - Credit Card Business, sees the importance of health care for women especially with pelvic examination, therefore in association with Women Health Center of Bangkok

Venus Medtech Enters North American Market Heathcare—๑๔ มิ.ย. ๖๑

HANGZHOU, China and VANCOUVER, Canada--14 Jun--PRNewswire/InfoQuest

On June 12, 2018, St Paul 's Hospital in Vancouver, Canada successfully completed two cases of VenusP-Valve self-expanding pulmonary valve implantation. This is the first appearance of Venus Medtech's transcatheter valve products in North America. The pace of internationalization continues to move forward.

Although surgical treatment of congenital heart disease has evolved dramatically in recent decades, operations involving the right ventricular outflow tract (RVOT) can still result in chronic pulmonary regurgitation, necessitating either surgical or percutaneous pulmonary valve implantation.

Percutaneous pulmonary valve implantation has emerged as a successful alternative to surgical valve implantation in such patients. However, the currently available balloon-expandable percutaneous valves are suitable only for outflow tracts reconstructed with cylindrical surgical tubes. Treatment of pulmonary regurgitation in the setting of prior RVOT patch augmentation has traditionally been limited to surgical intervention. This is mainly due to the limited available sizes of balloon-expandable valves relative to often se

What You Think About Getting Old Impacts Your Health, Quality of Life According to New Orb Media Heathcare—๑๓ มิ.ย. ๖๑

New Orb Media Inc. reporting and data analysis [ https://www.orbmedia.org/agewell ] shows a strong connection between how we view old age, how well we age and the effects seen across world cultures. Individuals with a positive attitude towards old age

Johnson Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Heathcare—๑๓ มิ.ย. ๖๑

Johnson & Johnson (NYSE: JNJ) today announced that it has accepted the binding offer from Platinum Equity, previously announced on March 16, 2018, to acquire its LifeScan business for approximately $2.1 billion. LifeScan, Inc. is a world leader in

Joint Commission International Appoints New Leadership in Key Strategic Heathcare—๑๒ มิ.ย. ๖๑

Joint Commission International (JCI) is pleased to announce John Yoon, MBA , as JCI's managing director of the Asia-Pacific Region. In this role, he is responsible for developing relationships between JCI and health care organizations, governments,

Two Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with Heathcare—๕ มิ.ย. ๖๑

- Two-year follow-up data on meaningful durable response, overall survival (OS) and progression-free survival (PFS) to be presented in patients with metastatic Merkel cell carcinoma (mMCC), a rare and aggressive type of skin cancer Merck and Pfizer

Merck Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO Heathcare—๕ มิ.ย. ๖๑

M7824 (TGF-ss trap/anti-PD-L1): 3007, 9017, 2566, TPS3130; Tepotinib (c-Met kinase inhibitor): 9082, 9016; M2698 (dual p70S6k/Akt inhibitor): 2584; M6620 (ATR inhibitor): 2549; M3814 (DNA-PK): 2518 Not intended for UK- or US-based media - M7824 is an

Takeda Highlights Favorable Safety Profile of Entyvio(R) (vedolizumab) Through Comparative Heathcare—๔ มิ.ย. ๖๑

Takeda demonstrates leadership in GI by featuring new U.S. VICTORY Consortium data among its 24 sponsored Entyvio abstracts presented at the Digestive Disease Week (DDW) 2018 meeting Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") today

Merck Presents Update on Tepotinib in Advanced Lung Cancer at ASCO Heathcare—๔ มิ.ย. ๖๑

Tepotinib (c-Met kinase inhibitor): 9082, 9016; M7824 (TGF-ss trap/anti-PD-L1): 3007, 9017, 2566; M2698 (dual p70S6k/Akt inhibitor): 2584; M6620 (ATR inhibitor): 2549; M3814 (DNA-PK): 2518 Not intended for UK- or US-based media - Data from an ongoing

Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Heathcare—๑ มิ.ย. ๖๑

Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which they can work together to achieve 'clear' (IGA 0)

Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of Heathcare—๑ มิ.ย. ๖๑

Menarini Ricerche (Menarini Group) will present at ASCO Annual Meeting 2018 the study design of CD205-Shuttle, a multicenter first-in-human clinical study to evaluate MEN1309/OBT076, an antibody drug conjugate (ADC) investigated for the treatment of

NW Bio To Discuss Interim Phase 3 Trial Data In Industry Theater Session During Heathcare—๑ มิ.ย. ๖๑

Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax(R) personalized immune therapies for solid tumor cancers, announced that on Sunday, June 3, at 4:15 p.m. Central Time in the Industry Expert Theater in the Exhibit

Herbalife Nutrition To Host Run For Life 3, Its Nationwide Sports Event to Promote Healthy, Active Heathcare—๑ มิ.ย. ๖๑

As a company whose purpose is to make the world healthier and happier, global nutrition company Herbalife Nutrition, invites runners of all levels to participate in "Run For Life 3", the largest running event ever held by Herbalife Nutrition Thailand, to

DxTerity Diagnostics Receives CE Mark for the REDI-Dx(R) Radiation Biodosimetry Heathcare—๓๐ พ.ค. ๖๑

DxTerity Diagnostics has declared conformity with the requirements of the European In Vitro Diagnostic Directive (98/79/EC) and has applied the CE mark to the REDI-Dx(R) Radiation Biodosimetry Test for the quantitative estimation of the absorbed ionizing

World Heart Federation: Tobacco is Responsible For More Than One in Ten Deaths Caused by Heathcare—๓๐ พ.ค. ๖๑

- The theme of WHO World No Tobacco Day 2018 on 31 May is: "Tobacco breaks hearts, choose health and not tobacco" - Smoking is associated with around 7 million global deaths per year and is an independent, major risk factor for myocardial infarction,

Getinge announces results from SEMPER FI pilot study of intra-aortic balloon pump showing numerical Heathcare—๒๘ พ.ค. ๖๑

Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia Following IABP Implantation (SEMPER FI) pilot study. The study

ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA Heathcare—๒๕ พ.ค. ๖๑

At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. (Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg ) ESMO advocated the strengthening of health

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Heathcare—๒๔ พ.ค. ๖๑

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral Heathcare—๒๔ พ.ค. ๖๑

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Heathcare—๒๓ พ.ค. ๖๑

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan.

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Heathcare—๒๑ พ.ค. ๖๑

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed

NovoEight(R) Maintains Potency When Stored at 40?C Offering People With Haemophilia A Increased Heathcare—๒๑ พ.ค. ๖๑

A new long term stability study has shown that haemophilia A treatment NovoEight(R) (turoctocog alfa) remains potent after three months exposure to temperatures of 40ºC.[1] The results were presented today at the WFH 2018 World Congress in Glasgow,

The Mall Shopping Center and Government Savings Bank Co-host The Mall Health Beauty Expo Heathcare—๑๗ พ.ค. ๖๑

The Mall Shopping Center, Government Savings Bank, leading hospitals and health institutions are co-hosting an annual grand event, "The Mall Health & Beauty Expo 2018" on June 28 – July 4, 2018 at the Grand Hall, G Floor, The Mall Bangkapi.

Merck Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Heathcare—๑๗ พ.ค. ๖๑

ASCO Abstract # ERBITUX(R) (cetuximab): 3521, 3534, e15711; avelumab: 9507, 9537, 9090, 9008, 8563, 3057, 4544, e21531, e13603, e18932, e21623, e21620, e21544; tepotinib (c-Met kinase inhibitor): 9082, 9016; M6620 (ATR inhibitor): 2549, e21048; M3814